Stockscreener 앱 받기
46.59
3.02%
-1.45
Vaxcyte Inc 주식(PCVX)의 최신 뉴스
Vaxcyte, Inc. (NASDAQ:PCVX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Vaxcyte (NASDAQ:PCVX) Trading 7.4% HigherWhat's Next? - MarketBeat
Aug Update: Can Vaxcyte Inc stock hit record highs againCPI Data & Technical Entry and Exit Alerts - Bộ Nội Vụ
(PCVX) Volatility Zones as Tactical Triggers - Stock Traders Daily
Aug Patterns: Why Vaxcyte Inc. (5VA) stock remains stableTrade Analysis Summary & Proven Capital Preservation Methods - Bộ Nội Vụ
Vaxcyte, Inc. (PCVX) Stock Analysis: A Look At Its 121.74% Potential Upside - DirectorsTalk Interviews
Analyst Calls: Will Vaxcyte Inc. (5VA) stock test record highs in 2025Weekly Stock Analysis & Real-Time Market Sentiment Reports - Bộ Nội Vụ
CEO Change: Why Vaxcyte Inc stock could benefit from AI revolutionQuarterly Trade Summary & Expert Approved Momentum Ideas - moha.gov.vn
How Vaxcyte Inc. stock performs after earningsRecovery Day Options & choose cushioning that matches your runs - Улправда
Why Vaxcyte Inc. (5VA) stock could rally stronglyLong Run Comfort Guide & updated model highlights and notes - Улправда
Cantor Fitzgerald Maintains Overweight on Vaxcyte Amid Vaccine Development and ACIP Meeting - MSN
How Vaxcyte Inc. (5VA) stock responds to bond market2025 Key Lessons & High Conviction Trade Alerts - Улправда
Why Vaxcyte Inc. stock could benefit from AI revolutionJuly 2025 Analyst Calls & Weekly Top Gainers Trade List - Улправда
Why Vaxcyte Inc. stock attracts high net worth investorsJuly 2025 Weekly Recap & Expert Verified Stock Movement Alerts - Улправда
Is Vaxcyte Inc. (5VA) stock positioned for digital growth eraJuly 2025 Macro Moves & Free Community Consensus Stock Picks - Улправда
Will Vaxcyte Inc. (5VA) stock test record highs in 20252025 Trade Ideas & Long-Term Growth Plans - Улправда
Why Vaxcyte Inc. (5VA) stock remains stableMoving Average Strategies & Secret Picks Wall Street Isn’t Talking About - Улправда
Vaxcyte (PCVX) Gains Positive Outlook with Price Target Boost - GuruFocus
Evercore ISI reiterates Outperform rating on Vaxcyte stock amid CDC changes - Investing.com Canada
Stock Report: Is Vaxcyte Inc stock trading near support levelsSell Signal & Daily Profit Maximizing Trade Tips - moha.gov.vn
Vaxcyte (PCVX) Gains Favor After Immunization Schedule Update - GuruFocus
Vaxcyte, Inc. (PCVX) Stock Analysis: Biotech Innovator With Nearly 100% Upside Potential - DirectorsTalk Interviews
Vaxcyte Earnings Notes - Trefis
Vaxcyte's Chief Technical Ops Officer Sells Shares - AOL.com
Insider Sell Alert: Harpreet Dhaliwal Sells 9,743 Shares of Vaxc - GuruFocus
Harpreet Dhaliwal Sells 9,743 Shares of Vaxcyte (NASDAQ:PCVX) Stock - MarketBeat
Vaxcyte Inc. (PCVX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Price-Driven Insight from (PCVX) for Rule-Based Strategy - Stock Traders Daily
Vaxcyte, Inc. (NASDAQ:PCVX) Nasdaq Composite Tracks Clinical Progress - Kalkine Media
Vaxcyte shows rising price performance with jump to 81 RS rating - MSN
Trade Alert: Senior Vice President of Finance Of Vaxcyte Elvia Cowan Has Sold Stock - simplywall.st
Vaxcyte (NASDAQ:PCVX) Stock Price Up 3.9%Here's Why - MarketBeat
Insider Selling: Vaxcyte (NASDAQ:PCVX) SVP Sells 11,623 Shares of Stock - MarketBeat
Vaxcyte president and CFO sells shares worth $692,100 - MSN
Vaxcyte, Inc. $PCVX Shares Sold by Harbor Capital Advisors Inc. - MarketBeat
This Pharma Stock Had a Rough Year. Why One Analyst Thinks It Can Rise 250%. - Barron's
What Makes Vaxcyte (PCVX) So Attractive - Finviz
What makes Vaxcyte (PCVX) so attractive - MSN
How (PCVX) Movements Inform Risk Allocation Models - Stock Traders Daily
Vaxcyte, Inc. (NASDAQ:PCVX) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Why Vaxcyte Inc. stock remains resilientJuly 2025 Spike Watch & Weekly Watchlist of Top Performers - Улправда
Assenagon Asset Management S.A. Buys 171,974 Shares of Vaxcyte, Inc. $PCVX - MarketBeat
Will Vaxcyte Inc. stock keep outperforming rivalsM&A Rumor & Risk Adjusted Buy and Sell Alerts - ulpravda.ru
How Vaxcyte Inc. stock performs during Fed tightening cyclesDay Trade & Safe Capital Allocation Plans - Улправда
How Vaxcyte Inc. stock performs in rate cut cyclesAnalyst Downgrade & Safe Capital Growth Trade Ideas - Улправда
Vaxcyte Enhances Executive Severance to Align With Market - TipRanks
PCVX (Vaxcyte) EV-to-OCF : -7.70 (As of Dec. 19, 2025) - GuruFocus
Profit Review: Will Vaxcyte Inc. stock attract ESG investorsWeekly Risk Summary & Reliable Intraday Trade Plans - DonanımHaber
Vaxcyte enhances executive severance to align with market - MSN
4.73%
0.92%
자본화:
|
볼륨(24시간):